{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:20:52Z","timestamp":1760142052733,"version":"build-2065373602"},"reference-count":57,"publisher":"Jaypee Brothers Medical Publishing","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.59556\/japi.73.1030","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T01:19:02Z","timestamp":1750987142000},"page":"e1-e9","source":"Crossref","is-referenced-by-count":0,"title":["A Comparative Systematic Review and Meta-analysis of Amitriptyline with Propranolol and Flunarizine for the Prophylaxis of Migraine Headache"],"prefix":"10.59556","volume":"73","author":[{"given":"AV","family":"Srinivasan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Bhanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2914","reference":[{"key":"key20251010055831_B1","doi-asserted-by":"crossref","first-page":"137.","DOI":"10.1186\/s10194-020-01208-0","article-title":"Migraine remains second among the world\u2019s causes of disability, and first among young women: findings from GBD2019.","volume":"21:","author":"Steiner","year":"2020;","journal-title":"J Headache Pain"},{"key":"key20251010055831_B2","doi-asserted-by":"crossref","first-page":"1307413.","DOI":"10.3389\/fneur.2023.1307413","article-title":"Temporal trends of migraine and tension-type headache burden across the BRICS: implications from the Global Burden of Disease study 2019.","volume":"14:","author":"Zhang","year":"2023;","journal-title":"Front Neurol"},{"key":"key20251010055831_B3","doi-asserted-by":"crossref","first-page":"274\u2013","DOI":"10.1007\/s13311-017-0592-1","article-title":"Migraine treatment: current acute medications and their potential mechanisms of action.","volume":"15:","author":"Ong","year":"2018;","journal-title":"Neurotherapeutics"},{"issue":"(4):","key":"key20251010055831_B4","first-page":"243\u2013","article-title":"Acute migraine headache: treatment strategies.","volume":"97","author":"Mayans","year":"2018;","journal-title":"Am Fam Physician"},{"issue":"(6):","key":"key20251010055831_B5","doi-asserted-by":"crossref","first-page":"1155\u2013","DOI":"10.2147\/NDT.S3497","article-title":"Prophylaxis of migraine: general principles and patient acceptance.","volume":"4","author":"D\u2019Amico","year":"2008;","journal-title":"Neuropsychiatr Dis Treat"},{"key":"key20251010055831_B6","first-page":"26\u2013","article-title":"Migraine: prophylactic treatment.","volume":"58:","author":"Shukla","year":"2010;","journal-title":"J Assoc Physicians India"},{"key":"key20251010055831_B7","unstructured":"Kumar A, Kadian R. Migraine Prophylaxis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK507873\/."},{"issue":"(5):","key":"key20251010055831_B8","doi-asserted-by":"crossref","first-page":"341\u2013","DOI":"10.1136\/ewjm.173.5.341","article-title":"Migraine prophylaxis in adult patients.","volume":"173","author":"Parsekyan","year":"2000;","journal-title":"West J Med"},{"issue":"(2):","key":"key20251010055831_B9","first-page":"CD003225.","article-title":"Propranolol for migraine prophylaxis.","author":"Linde","year":"2004;","journal-title":"Cochrane Database Syst Rev"},{"issue":"(1):","key":"key20251010055831_B10","doi-asserted-by":"crossref","first-page":"128.","DOI":"10.1186\/s10194-023-01657-3","article-title":"European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention-part 2: flunarizine.","volume":"24","author":"Deligianni","year":"2023;","journal-title":"J Headache Pain"},{"key":"key20251010055831_B11","article-title":"Cochrane Handbook for Systematic Reviews of Interventions, 2nd edition.","volume-title":"Hoboken.","author":"Higgins","year":"2019."},{"issue":"(10):","key":"key20251010055831_B12","doi-asserted-by":"crossref","first-page":"1127\u2013","DOI":"10.1136\/jnnp-2016-313458","article-title":"Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention.","volume":"87","author":"Gon\u00e7alves","year":"2016;","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key20251010055831_B13","doi-asserted-by":"crossref","first-page":"179\u2013","DOI":"10.1007\/s101940070041","article-title":"A comparative study of magnesium, flunarizine and amitriptyline in the prophylaxis of migraine.","volume":"1:","author":"Demirkaya","year":"2000;","journal-title":"J Headache Pain"},{"issue":"(3):","key":"key20251010055831_B14","first-page":"86\u2013","article-title":"Propranolol versus amitriptyline for prophylaxis: a prospective study.","volume":"12","author":"Raza","year":"2022;","journal-title":"Eur J Cardiovasc Med"},{"issue":"(4-S):","key":"key20251010055831_B15","first-page":"1022\u2013","article-title":"Comparative study to evaluate the efficacy and safety of propranolol versus amitriptyline for prophylaxis of migraine.","volume":"9","author":"Pandey","year":"2019;","journal-title":"J Drug Deliv Ther"},{"issue":"(S1):","key":"key20251010055831_B16","doi-asserted-by":"crossref","first-page":"7379\u2013","DOI":"10.53730\/ijhs.v6nS1.6578","article-title":"Comparison of propranolol versus amitriptyline as monotherapy for migraine prophylaxis.","volume":"6","author":"Gorukanti","year":"2022;","journal-title":"Int J Health Sci"},{"issue":"(4):","key":"key20251010055831_B17","doi-asserted-by":"crossref","first-page":"423\u2013","DOI":"10.1111\/j.1468-2982.2008.01749.x","article-title":"Effective prophylactic treatments of migraine lower plasma glutamate levels.","volume":"29","author":"Ferrari","year":"2009;","journal-title":"Cephalalgia"},{"issue":"(7):","key":"key20251010055831_B18","doi-asserted-by":"crossref","first-page":"31\u2013","DOI":"10.22159\/ijpps.2022v14i7.44151","article-title":"To evaluate the efficacy, safety and tolerability of oral propranolol comparison with oral amitriptyline for migraine prophylaxis.","volume":"14","author":"Jyothi","year":"2022;","journal-title":"Int J Pharm Pharm Sci"},{"issue":"(24):","key":"key20251010055831_B19","first-page":"166\u2013","article-title":"Efficacy of amitriptyline versus propranolol for prophylaxis of migraine: a comparative study.","volume":"4","author":"Singh","year":"2021;","journal-title":"Int J Health Clin Res"},{"issue":"(4):","key":"key20251010055831_B20","first-page":"179\u2013","article-title":"Oral flunarizine versus oral amitriptyline in migraine prophylaxis\u2014a prospective open label study.","volume":"5","author":"Bhavani","year":"2018;","journal-title":"Indian J Pharm Pharmacol"},{"issue":"(3):","key":"key20251010055831_B21","doi-asserted-by":"crossref","first-page":"305\u2013","DOI":"10.1097\/01.wco.0000169750.52406.a2","article-title":"Comorbidity of migraine.","volume":"18","author":"Scher","year":"2005;","journal-title":"Curr Opin Neurol"},{"issue":"(1):","key":"key20251010055831_B22","doi-asserted-by":"crossref","first-page":"23.","DOI":"10.1186\/s10194-020-1084-y","article-title":"Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study.","volume":"21","author":"Buse","year":"2020;","journal-title":"J Headache Pain"},{"issue":"(2):","key":"key20251010055831_B23","doi-asserted-by":"crossref","first-page":"91\u2013","DOI":"10.1080\/08964289.2015.1086721","article-title":"Comorbidity in migraine with functional somatic syndromes, psychiatric disorders and inflammatory diseases: a matter of central sensitization?","volume":"43","author":"Grassini","year":"2017;","journal-title":"Behav Med"},{"key":"key20251010055831_B24","doi-asserted-by":"crossref","first-page":"71.","DOI":"10.1186\/s10194-021-01281-z","article-title":"Comorbidities of primary headache disorders: a literature review with meta-analysis.","volume":"22:","author":"Caponnetto","year":"2021;","journal-title":"J Headache Pain"},{"key":"key20251010055831_B25","doi-asserted-by":"crossref","first-page":"640574.","DOI":"10.3389\/fnhum.2021.640574","article-title":"Pathophysiological bases of comorbidity in migraine.","volume":"15:","author":"Altamura","year":"2021;","journal-title":"Front Hum Neurosci"},{"issue":"(3):","key":"key20251010055831_B26","doi-asserted-by":"crossref","first-page":"306\u2013","DOI":"10.1111\/head.13459","article-title":"Migraine progression: a systematic review.","volume":"59","author":"Buse","year":"2019;","journal-title":"Headache"},{"key":"key20251010055831_B27","doi-asserted-by":"crossref","first-page":"51.","DOI":"10.1186\/s10194-019-0988-x","article-title":"Understanding the nature of psychiatric comorbidity in migraine: a systematic review focused on interactions and treatment implications.","volume":"20:","author":"Dresler","year":"2019;","journal-title":"J Headache Pain"},{"issue":"(1):","key":"key20251010055831_B28","first-page":"1\u2013","article-title":"Treatment of migraine attacks and prevention of migraine: guidelines by the German Migraine and Headache Society and the German Society of Neurology.","volume":"3","author":"Diener","year":"2019;","journal-title":"Clin Transl Neurosci"},{"issue":"(3):","key":"key20251010055831_B29","doi-asserted-by":"crossref","first-page":"173\u2013","DOI":"10.1016\/0022-3956(72)90019-2","article-title":"Catecholamine metabolism in affective disorders. IV. Preliminary studies of norepinephrine metabolism in depressed patients treated with amitriptyline.","volume":"9","author":"Schildkraut","year":"1972;","journal-title":"J Psychiatr Res"},{"issue":"(4):","key":"key20251010055831_B30","doi-asserted-by":"crossref","first-page":"322\u2013","DOI":"10.1159\/000080960","article-title":"Evaluation of the prophylactic efficacy of amitriptyline and citalopram, alone or in combination, in patients with comorbidity of depression, migraine, and tension-type headache.","volume":"50","author":"Rampello","year":"2004;","journal-title":"Neuropsychobiology"},{"key":"key20251010055831_B31","unstructured":"Amitriptyline Summary of Product Characteristics Updated. Accord-UK Ltd. Available from: https:\/\/www.accord-healthcare-products.co.uk\/products\/a\/amitriptyline-tablets."},{"key":"key20251010055831_B32","unstructured":"Drug Information Sheet Amitriptyline Hydrochloride. Available from: https:\/\/www.rad-ar.or.jp\/siori\/english\/search\/result?n=32615."},{"issue":"(1):","key":"key20251010055831_B33","doi-asserted-by":"crossref","first-page":"39.","DOI":"10.1186\/s10194-023-01573-6","article-title":"European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention-part 1: amitriptyline.","volume":"24","author":"Lampl","year":"2023;","journal-title":"J Headache Pain"},{"issue":"(2 Suppl 2):","key":"key20251010055831_B34","first-page":"S1\u2013","article-title":"Canadian Headache Society guideline for migraine prophylaxis.","volume":"39","author":"Pringsheim","year":"2012;","journal-title":"Can J Neurol Sci"},{"key":"key20251010055831_B35","doi-asserted-by":"crossref","first-page":"S31\u2013","DOI":"10.1007\/s10194-012-0437-6","article-title":"Italian guidelines for primary headaches: 2012 revised version.","volume":"13:","author":"Sarchielli","year":"2012;","journal-title":"J Headache Pain"},{"issue":"(2):","key":"key20251010055831_B36","first-page":"e54270.","article-title":"Indian consensus on the role of amitriptyline in migraine prophylaxis.","volume":"16","author":"Singh","year":"2024;","journal-title":"Cureus"},{"key":"key20251010055831_B37","doi-asserted-by":"crossref","first-page":"S52\u2013","DOI":"10.1111\/j.1526-4610.2007.00677.x","article-title":"Current trends in migraine prophylaxis.","volume":"47:","author":"Ramadan","year":"2007;","journal-title":"Headache"},{"key":"key20251010055831_B38","doi-asserted-by":"crossref","first-page":"126.","DOI":"10.1186\/s10194-020-01192-5","article-title":"Migraine and sleep disorders: a systematic review.","volume":"21:","author":"Tiseo","year":"2020;","journal-title":"J Headache Pain"},{"key":"key20251010055831_B39","doi-asserted-by":"crossref","first-page":"267\u2013","DOI":"10.1007\/BF00426633","article-title":"The relationship between changes in REM sleep and clinical improvement in depressed patients treated with amitriptyline.","volume":"59:","author":"Gillin","year":"1978;","journal-title":"Psychopharmacology (Berl)"},{"issue":"(1):","key":"key20251010055831_B40","doi-asserted-by":"crossref","first-page":"93\u2013","DOI":"10.1345\/aph.18150","article-title":"Drug-induced nightmares.","volume":"33","author":"Thompson","year":"1999;","journal-title":"Ann Pharmacother"},{"issue":"(12):","key":"key20251010055831_B41","doi-asserted-by":"crossref","first-page":"1441\u2013","DOI":"10.1177\/02698811211034810","article-title":"\u03b2-adrenoceptor antagonists and nightmares: a pharmacoepidemiological\u2013pharmacodynamic study.","volume":"35","author":"Garcia","year":"2021;","journal-title":"J Psychopharmacol"},{"key":"key20251010055831_B42","first-page":"CD008242.","article-title":"Amitriptyline for neuropathic pain and fibromyalgia in adults.","volume":"12:","author":"Moore","year":"2012;","journal-title":"Cochrane Database Syst Rev"},{"issue":"(4):","key":"key20251010055831_B43","doi-asserted-by":"crossref","first-page":"281\u2013","DOI":"10.1111\/j.1365-2044.1993.tb06943.x","article-title":"Dose-response for analgesic effect of amitriptyline in chronic pain.","volume":"48","author":"McQuay","year":"1993;","journal-title":"Anaesthesia"},{"issue":"(11):","key":"key20251010055831_B44","doi-asserted-by":"crossref","first-page":"1474\u2013","DOI":"10.1001\/jamainternmed.2018.4222","article-title":"Efficacy of low-dose amitriptyline for chronic low back pain: a randomized clinical trial.","volume":"178","author":"Urquhart","year":"2018;","journal-title":"JAMA Intern Med"},{"issue":"(2):","key":"key20251010055831_B45","doi-asserted-by":"crossref","first-page":"45\u2013","DOI":"10.3126\/njn.v18i2.34465","article-title":"A comparative analysis of amytripiline, flunnarazine and topiramate in the treatment of primary headache.","volume":"18","author":"Pokharel","year":"2021;","journal-title":"Nepal J Neurosci"},{"issue":"(10):","key":"key20251010055831_B46","doi-asserted-by":"crossref","first-page":"1626\u2013","DOI":"10.1111\/head.12987","article-title":"Amitriptyline dose and treatment outcomes in specialty headache practice: a retrospective cohort study","volume":"56","author":"Strauss","year":"2016;","journal-title":"Headache"},{"key":"key20251010055831_B47","doi-asserted-by":"crossref","first-page":"1013\u2013","DOI":"10.1007\/s00405-020-05802-5","article-title":"Analysis of the effectiveness of the prophylaxis of vestibular migraine depending on the diagnostic category and the prescribed drug.","volume":"277:","author":"Dom\u00ednguez-Dur\u00e1n","year":"2020;","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"key20251010055831_B48","doi-asserted-by":"crossref","first-page":"404\u2013","DOI":"10.1016\/j.bjorl.2016.04.022","article-title":"Prophylactic treatment of vestibular migraine.","volume":"83:","author":"Salmito","year":"2016;","journal-title":"Braz J Otorhinolaryngol"},{"issue":"(7):","key":"key20251010055831_B49","doi-asserted-by":"crossref","first-page":"451\u2013","DOI":"10.1111\/j.1526-4610.1991.hed3107451.x","article-title":"Post-traumatic migraine: chronic migraine precipitated by minor head or neck trauma.","volume":"31","author":"Weiss","year":"1991;","journal-title":"Headache"},{"issue":"(5-S):","key":"key20251010055831_B50","doi-asserted-by":"crossref","first-page":"40\u2013","DOI":"10.22270\/jddt.v9i5-s.3597","article-title":"Assessment of quality of life and compare the impact of amitriptyline and propranolol in migraine patients.","volume":"9","author":"Kothiyal","year":"2019;","journal-title":"J Drug Deliv Ther"},{"issue":"(3):","key":"key20251010055831_B51","first-page":"298\u2013","article-title":"Sleep changes during prophylactic treatment of migraine.","volume":"18","author":"Duman","year":"2015;","journal-title":"Ann Indian Acad Neurol"},{"key":"key20251010055831_B52","doi-asserted-by":"crossref","first-page":"15.","DOI":"10.1186\/s10194-015-0496-6","article-title":"Cost-effectiveness analysis of interventions for migraine in four low-and middle-income countries.","volume":"16:","author":"Linde","year":"2015;","journal-title":"J Headache Pain"},{"issue":"(5):","key":"key20251010055831_B53","doi-asserted-by":"crossref","first-page":"543\u2013","DOI":"10.1177\/0333102410392605","article-title":"Migraine preventive drug-induced weight gain may be mediated by effects on hypothalamic peptides: the results of a pilot study.","volume":"31","author":"Caproni","year":"2011;","journal-title":"Cephalalgia"},{"issue":"(11):","key":"key20251010055831_B54","doi-asserted-by":"crossref","first-page":"1048\u2013","DOI":"10.1111\/j.1468-2982.2005.00956.x","article-title":"Comparison of the effects of amitriptyline and flunarizine on weight gain and serum leptin, C peptide and insulin levels when used as migraine preventive treatment.","volume":"25","author":"Berilgen","year":"2005;","journal-title":"Cephalalgia"},{"key":"key20251010055831_B55","doi-asserted-by":"crossref","first-page":"771.","DOI":"10.3389\/fneur.2019.00771","article-title":"Prophylactic treatment of pediatric migraine: is there anything new in the last decade?","volume":"10:","author":"Papetti","year":"2019;","journal-title":"Front Neurol"},{"issue":"(10):","key":"key20251010055831_B56","doi-asserted-by":"crossref","first-page":"e465111033013.","DOI":"10.33448\/rsd-v11i10.33013","article-title":"Amitriptyline: useful for the prophylactic treatment of migraine?","volume":"11","author":"dos Santos Pereira","year":"2022;","journal-title":"Res Soc Dev"},{"key":"key20251010055831_B57","doi-asserted-by":"crossref","first-page":"36\u2013","DOI":"10.1007\/s11940-011-0157-2","article-title":"Posttraumatic headache in military personnel and veterans of the Iraq and Afghanistan conflicts.","volume":"14:","author":"Theeler","year":"2012;","journal-title":"Curr Treat Options Neurol"}],"container-title":["Journal of The Association of Physicians of India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T05:58:47Z","timestamp":1760075927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.japi.org\/article\/japi-73-6-e1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.59556\/japi.73.1030"],"URL":"https:\/\/doi.org\/10.59556\/japi.73.1030","relation":{},"ISSN":["0004-5772"],"issn-type":[{"type":"print","value":"0004-5772"}],"subject":[],"published":{"date-parts":[[2025,6]]}}}